Video

The Evolution of the Multi-CDMO Strategy

Source: Outsourced Pharma

This segment of the Outsourced Pharma Live event, "One Program Many CDMOs: Managing Multi-Partner Strategies," addresses the root causes driving the multi-partner model. The panelists discuss how the industry shifted from mitigating capacity constraints to intentionally chasing specialized technologies and diversifying risk. They also examine the importance of pursuing technical expertise and proven delivery capabilities across different partners. Featuring panelists D.J. Harkins, Director, LVV Manufacturing and MS&T at Genetix, Laura Deschenes, PhD, Founder and Principal at Deschenes Consulting LLC, and Mark Davis, Founder & Principal at NegotiumBio.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)